These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Identification of the Benignity and Malignancy of BI-RADS 4 Breast Lesions Based on a Combined Quantitative Model of Dynamic Contrast-Enhanced MRI and Intravoxel Incoherent Motion. Xu W, Zheng B, Li H. Tomography; 2022 Oct 31; 8(6):2676-2686. PubMed ID: 36412682 [Abstract] [Full Text] [Related]
25. Differentiating between malignant and benign solid solitary pulmonary lesions: are intravoxel incoherent motion and diffusion kurtosis imaging superior to conventional diffusion-weighted imaging? Wan Q, Deng YS, Lei Q, Bao YY, Wang YZ, Zhou JX, Zou Q, Li XC. Eur Radiol; 2019 Mar 31; 29(3):1607-1615. PubMed ID: 30255258 [Abstract] [Full Text] [Related]
26. Diffusion Kurtosis at 3.0T as an in vivo Imaging Marker for Breast Cancer Characterization: Correlation With Prognostic Factors. Huang Y, Lin Y, Hu W, Ma C, Lin W, Wang Z, Liang J, Ye W, Zhao J, Wu R. J Magn Reson Imaging; 2019 Mar 31; 49(3):845-856. PubMed ID: 30260589 [Abstract] [Full Text] [Related]
39. Intravoxel incoherent motion diffusion-weighted MR imaging for characterization of focal pancreatic lesions. Kang KM, Lee JM, Yoon JH, Kiefer B, Han JK, Choi BI. Radiology; 2014 Feb 31; 270(2):444-53. PubMed ID: 24126370 [Abstract] [Full Text] [Related]
40. Intravoxel incoherent motion MRI for the differentiation of benign, intermediate, and malignant solid soft-tissue tumors. Wu H, Zhang S, Liang C, Liu H, Liu Y, Mei Y, Liu H, Liu Z, Xu F. J Magn Reson Imaging; 2017 Dec 31; 46(6):1611-1618. PubMed ID: 28419705 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]